[HTML][HTML] Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson… - PLoS …, 2019 - journals.plos.org
Background A nonsputum blood test capable of predicting progression of healthy individuals
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson… - PLOS …, 2019 - econpapers.repec.org
Background: A nonsputum blood test capable of predicting progression of healthy
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study.
A Penn-Nicholson, T Hraha, EG Thompson, D Sterling… - 2019 - cabidigitallibrary.org
Background: A nonsputum blood test capable of predicting progression of healthy
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
[PDF][PDF] Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson… - PLoS Medicine, 2019 - pure.mpg.de
Background A nonsputum blood test capable of predicting progression of healthy individuals
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
[PDF][PDF] Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson… - PLoS …, 2019 - pdfs.semanticscholar.org
Background A nonsputum blood test capable of predicting progression of healthy individuals
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson… - PLOS …, 2019 - ideas.repec.org
Background: A nonsputum blood test capable of predicting progression of healthy
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
A Penn-Nicholson, T Hraha, EG Thompson… - PLoS …, 2019 - search.ebscohost.com
Abstract < bold> Background: </bold> A nonsputum blood test capable of predicting
progression of healthy individuals to active tuberculosis (TB) before clinical symptoms …
progression of healthy individuals to active tuberculosis (TB) before clinical symptoms …
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson, D Sterling… - 2019 - scholar.sun.ac.za
Background: A nonsputum blood test capable of predicting progression of healthy
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
individuals to active tuberculosis (TB) before clinical symptoms manifest would allow …
[PDF][PDF] Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson, D Sterling… - PLoS Med, 2019 - core.ac.uk
Background A nonsputum blood test capable of predicting progression of healthy individuals
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
A Penn-Nicholson, T Hraha, EG Thompson… - Plos …, 2019 - europepmc.org
Background A nonsputum blood test capable of predicting progression of healthy individuals
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …